Login / Signup
Afsheen Khan
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Prognostic Factors
Drug Administration
Mesenchymal Stem Cells
Endoplasmic Reticulum Stress
Top Venues
Rare tumors
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Taruba Rais
,
Afsheen Khan
,
Rumaisa Riaz
Elrexfio™ (elranatamab-bcmm): The game-changer in treatment of multiple myeloma.
Rare tumors
15 (2023)